Advertising disclosure — We may earn a commission if you start care through some of these links, at no extra cost to you. How we're funded. Order reflects our editorial rubric and our commercial relationships; scores are ours alone.
Head-to-head for women
Gala Health vs SkinnyRx
Gala Health and SkinnyRx both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
Gala Health
Higher scoreRanked #13 for women · Grade B
Luna Fit
Best for: Women who want compounded tirzepatide and hormone care from one provider, are comfortable committing to a year to get the advertised rate, and value having a brand-Ozempic escape hatch.
Visit Gala HealthSkinnyRx
Ranked #54 for women · Grade C
Luna Fit
Best for: Readers treating insulin resistance who want the dual GIP/GLP-1 molecule without a weekly injection, and who will open the plan selector and read the month-to-month rate rather than the advertised one.
FDA warning letterFebruary 2026Read it ↗Visit SkinnyRxThe verdict for women
Gala Health edges out SkinnyRx on the Luna Fit Score, 83 to 71 (B vs C). Women who want compounded tirzepatide and hormone care from one provider, are comfortable committing to a year to get the advertised rate, and value having a brand-Ozempic escape hatch. The reasoning behind that number is in the Gala Health scorecard.
SkinnyRx is still a genuine option — the rare program that compounds tirzepatide as a dissolving tablet as well as an injection — genuinely useful if the needle is what is stopping you — sold behind a four-rung commitment ladder whose cheapest rung is the only price the site ever shows you. Weigh the six women's-health factors below against your own priorities; the SkinnyRx scorecard goes through each of them, and if neither of these two is the one, our ranked shortlist of SkinnyRx alternatives widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Gala Health | SkinnyRx |
|---|---|---|
| Luna Fit Score | 83/100 · B | 71/100 · C |
| Overall rank | #13 | #54 |
| Semaglutide | $1,299/mo | $349/mo month-to-month (from $199/mo on a 12-month plan) — the site displays only the 12-month rate |
| Tirzepatide | $179/mo (yearly plan) | $399/mo month-to-month, injectable or dissolving tablet (from $299/mo on a 12-month plan) — the site displays only the 12-month rate |
| Coverage | All 50 states | No state list published; the offer terms report no state restrictions |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Yes |
Luna Fit
Gala Health
Ranked #13 · Grade B
What we like
- Built around women's care specifically, with an adjacent HRT and menopause line under the same roof
- All doses included at one price, so titrating up never raises the bill
- Available across all 50 states — a rare full-nationwide footprint
The caveats
- The $179 rate requires a yearly subscription — no month-to-month price is published anywhere, and the cheapest term the site quotes in prose is $199/mo on a 3-month plan
- The $149 microdose tier is a sub-therapeutic longevity protocol, not a cheaper weight-loss dose
- Compounded medication is not FDA-approved the way brand Ozempic or Zepbound are
Luna Fit
SkinnyRx
Ranked #54 · Grade C
What we like
- A compounded tirzepatide TABLET — a dissolving sublingual route for the dual GIP/GLP-1 molecule, priced identically to the injection at every rung, which is close to unique in this ranking
- Both molecules across three routes — injection, sublingual and daily tablet — so needle aversion never means changing provider or dropping back to the single-pathway drug
- Lower-dose "microdose" lines for both molecules are sold as their own products with their own published ladders, rather than being quoted at the full-dose price
The caveats
- Carries an active FDA warning letter issued in February 2026 (see the notice on this page for FDA's own record)
- Every price the site advertises is the TWELVE-MONTH rung: its own headline reads "Starting at $299/mo" while the month-to-month tirzepatide rate is $399 and the renewal price in its code is literally 399 — semaglutide is the same shape at $199 advertised against $349 month-to-month
- The commitment is not named beside the number anywhere in the marketing copy, and the prepay rung is also what its schema.org product markup publishes as the price — so search engines and AI assistants are given the twelve-month rate as though it were the monthly one
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither Gala Health nor SkinnyRx is only worth comparing with the other. Gala Health is also written up against CoreAge Rx, 10 points apart on the Luna Fit Score — see Gala Health against CoreAge Rx, factor by factor. SkinnyRx is also written up against CoreAge Rx, 22 points apart — see the SkinnyRx–CoreAge Rx head-to-head.
- Gala Health vs CoreAge Rx
- Gala Health vs Enhance MD
- Gala Health vs Eden
- SkinnyRx vs yourEra
- SkinnyRx vs Sesame Care
- SkinnyRx vs HealthRX
Or browse the full comparison hub.